Neoadjuvant Nab -paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX
Peterson, Shawn L, Husnain, Muhammad, Pollack, Terri, Pimentel, Agustin, Loaiza-Bonilla, Arturo, Westendorf-Overley, Colleen, Ratermann, Kelley, Anthony, Lowell, Desimone, Philip, Goel, Gaurav, Kudrimoti, Mahesh, Dineen, Sean, Tzeng, Ching-Wei D, Hosein, Peter J
Published in Anticancer research (01.07.2018)
Published in Anticancer research (01.07.2018)
Get full text
Journal Article
Neoadjuvant nab -paclitaxel and gemcitabine (AG) in borderline resectable (BR) or unresectable (UR) locally advanced pancreatic adenocarcinoma (LAPC) in patients ineligible for FOLFIRINOX
Peterson, Shawn, Loaiza-Bonilla, Arturo, Ben-Josef, Edgar, Drebin, Jeffrey A., Westendorf-Overley, Colleen, Anthony, Lowell Brian, DeSimone, Philip A., Goel, Gaurav, Kudrimoti, Mahesh R., Dineen, Sean Patrick, Tzeng, Ching-Wei David, Hosein, Peter J
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article